NCT02608515View on ClinicalTrials.gov

A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease

CompletedOBSERVATIONAL
Enrollment

207

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Relapsed/Refractory Multiple Myeloma
Trial Locations (1)

26443

Patra, Pátrai

Sponsors
All Listed Sponsors
lead

Genesis Pharma S.A.

INDUSTRY

NCT02608515 - A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease | Biotech Hunter | Biotech Hunter